Skip to content

Shanghai Clinical Cohort - Esophageal Cancer

Shanghai Clinical Cohort - Esophageal Cancer Cohort

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07312526
Enrollment
2116
Registered
2025-12-31
Start date
2025-07-01
Completion date
2026-03-31
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer, Esophagectomy

Keywords

esophageal cancer, esophagecomy

Brief summary

A prospective cohort of patients who received esophagectomy for esophageal cancer in participating centers.

Detailed description

A prospective cohort of patients who received esophagectomy for esophageal cancer in participating centers.

Interventions

PROCEDUREesophagectomy

esophagectomy

Sponsors

Shanghai Chest Hospital
Lead SponsorOTHER
Shanghai Zhongshan Hospital
CollaboratorOTHER
Shanghai Cancer Hospital, China
CollaboratorOTHER
Changhai hospital of Navy Medical University
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Received esophagectomy in these centers for esophageal cancer.

Exclusion criteria

* No esophagectomy.

Design outcomes

Primary

MeasureTime frame
Overal survivalFrom the date of enrollment until the date of death or loss of follow-up, assessed up to 10 years. Follow-up is scheduled every 3 months in the first 2 years. Every 6 months from the 2nd to the 5th year. Then once a year. Until death or loss of follow.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026